BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27514843)

  • 1. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.
    Littorin N; Ahl J; Uddén F; Resman F; Riesbeck K
    BMC Infect Dis; 2016 Aug; 16(1):407. PubMed ID: 27514843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Valent pneumococcal non-typeable
    Oguoma VM; Wilson N; Mulholland K; Santosham M; Torzillo P; McIntyre P; Smith-Vaughan H; Balloch A; Chatfield M; Lehmann D; Binks MJ; Chang A; Carapetis J; Krause V; Andrews R; Snelling T; Licciardi P; Morris P; Leach AJ
    BMJ Open; 2020 May; 10(5):e033511. PubMed ID: 32448790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic burden of acute otitis media caused by Streptococcus pneumoniae in European children, after widespread use of PCVs-A systematic literature review of published evidence.
    Ricci Conesa H; Skröder H; Norton N; Bencina G; Tsoumani E
    PLoS One; 2024; 19(4):e0297098. PubMed ID: 38564583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
    Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Wilson N; Arrowsmith B; Beissbarth J; Chatfield MD; Oguoma VM; Morris PS
    BMC Pediatr; 2021 Mar; 21(1):117. PubMed ID: 33685411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the serotype distribution of Streptococcus pneumoniae causing otitis media after PCV13 introduction in Spain.
    Morales M; Ludwig G; Ercibengoa M; Esteva C; Sanchez-Encinales V; Alonso M; Muñoz-Almagro C; Marimón JM
    PLoS One; 2018; 13(12):e0209048. PubMed ID: 30562385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccines.
    Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Skull SA; Oguoma VM; Chatfield M; Lehmann D; Binks MJ; Licciardi PV; Andrews R; Snelling T; Krause V; Carapetis J; Chang AB; Morris PS
    Int J Pediatr Otorhinolaryngol; 2023 Dec; 175():111776. PubMed ID: 37951020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland-A population-based time series analysis.
    Eythorsson E; Ásgeirsdóttir TL; Erlendsdóttir H; Hrafnkelsson B; Kristinsson KG; Haraldsson Á
    PLoS One; 2021; 16(4):e0249497. PubMed ID: 33831049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.
    Poolman J; Frasch C; Nurkka A; Käyhty H; Biemans R; Schuerman L
    Clin Vaccine Immunol; 2011 Feb; 18(2):327-36. PubMed ID: 21123523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic classification and antimicrobial resistance profiling of Streptococcus pneumoniae and Haemophilus influenza isolates associated with paediatric otitis media and upper respiratory infection.
    Lobb B; Lee MC; McElheny CL; Doi Y; Yahner K; Hoberman A; Martin JM; Hirota JA; Doxey AC; Shaikh N
    BMC Infect Dis; 2023 Sep; 23(1):596. PubMed ID: 37700242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine prevention of acute otitis media.
    Greenberg DP; Hoberman A
    Curr Allergy Asthma Rep; 2001 Jul; 1(4):358-63. PubMed ID: 11892059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice.
    Manning J; Manna S; Dunne EM; Bongcaron V; Pell CL; Patterson NL; Kuil SD; Dhar P; Goldblatt D; Kim Mulholland E; Licciardi PV; Robins-Browne RM; Malley R; Wijburg O; Satzke C
    Vaccine; 2024 Mar; 42(7):1714-1722. PubMed ID: 38350767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype-Dependent Inhibition of
    Lim S; Lee D; Jeong S; Park JW; Im J; Choi B; Gwak D; Yun CH; Seo HS; Han SH
    J Microbiol Biotechnol; 2024 Jan; 34(1):47-55. PubMed ID: 38044707
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen.
    Jang AY; Seo HS; Lin S; Chung GH; Kim HW; Lim S; Zhao L; Park IH; Lim JH; Kim KH
    Virulence; 2017 Aug; 8(6):875-890. PubMed ID: 28059611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises?
    Chandpa HH; Panda AK; Meena CL; Meena J
    Vaccine; 2023 Dec; 41(50):7515-7524. PubMed ID: 37980259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
    Leach AJ; Wilson N; Arrowsmith B; Beissbarth J; Mulholland K; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Skull SA; Oguoma VM; Chatfield MD; Lehmann D; Brennan-Jones CG; Binks MJ; Licciardi PV; Andrews RM; Snelling T; Krause V; Carapetis J; Chang AB; Morris PS
    PLoS Med; 2024 Jun; 21(6):e1004375. PubMed ID: 38829821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and qualification of an automated capillary Western method for the identification of polysaccharide serotypes in pneumococcal conjugate vaccine (PCV).
    Deiss A; Loughney JW; Rustandi RR; Vuolo K; Mackey MA
    J Pharm Biomed Anal; 2024 Jan; 238():115788. PubMed ID: 37866079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children.
    Howard LM; Grijalva CG
    Curr Opin Infect Dis; 2024 Jun; 37(3):170-175. PubMed ID: 38437245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to pneumococcal conjugate vaccine 10 among Nigerian children under 5 years.
    Udah CA; Iregbu FU; Ekanem EE
    Afr Health Sci; 2023 Jun; 23(2):186-192. PubMed ID: 38223616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ACUTE OTITIS MEDIA BACTERIOLOGY IN CHILDREN YOUNGER THAN THREE MONTHS IN THE LAST 16 YEARS].
    Paker M; Pichkhadze E; Miron D; Shlizerman L; Mazzawi S; Goldman T; Shupak A
    Harefuah; 2023 Nov; 162(9):598-604. PubMed ID: 37965857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Ewald H; Briel M; Vuichard D; Kreutle V; Zhydkov A; Gloy V
    Dtsch Arztebl Int; 2016 Mar; 113(9):139-46. PubMed ID: 26987462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.